News and updates
Reducing bureaucracy in clinical trials: now is the time!
Medical societies and patient advocates across disciplines have joined forces with EHA to call for urgent action to make clinical trials less bureaucratic and more patient-centered, efficient and cheaper.
Meet Achille Iolascon, our Volunteer of the Month
I serve the EHA as chairman of the Study working group on “Red cells and iron” since June 2014. It was a very fruitful and exciting period.
EHA-Baltic Hematology Tutorial on Bleeding Disorders & Thrombosis
EHA IN COLLABORATION WITH BALTIC SOCIETIES CONCLUDE THE FIRST HYBRID TUTORIAL MEETING IN EHA HISTORY! EHA-Baltic Hematology Tutorial on Bleeding Disorders & Thrombosis August 28 – 30, 2020 Virtual & Riga, Latvia Meeting Chairs: Prof…
Meet Robin Foà, our Volunteer of the Month
Professor Robin Foà has been a member of EHA from its beginning and has participated in all EHA Congresses. He was EHA President in 2009-2011, has participated in many educational activities of the association and is currently a member of the Global Outreach Program Committee of EHA.
EHA25 Virtual | News Room
Welcome to the news room of EHA25 Virtual where you can find the most relevant news items. Feel free to browse through the latest press releases below and make sure to keep an eye on this page for upcoming news items.
Meet Gert Ossenkoppele, our Volunteer of the Month
I am lucky to be one of the first members of the EHA (member number 34). I am involved as volunteer since 2009...
Call for urgent action on medicine shortages in Europe
EPHA published a position paper on medicine shortages in Europe. EHA welcomes its recommendations to address the increasing shortages crisis, which threatens patient outcomes and patient safety.
EHA-ISHBT Hematology Tutorial 2020
The 4th EHA-ISHBT Hematology Tutorial on Hematological Disorders was held on February 28 and 29 in Chandigarh, India, and chaired by Prof John Gribben, Prof Neelam Varma and Prof Pankaj Malhotra.
Guidelines for hematologists
EHA creates clinical practice guidelines for diagnosis and treatment of hematologic diseases. View the EHA methodology for guidelines, EHA Guidelines by topic and Guidelines produced by other societies and endorsed by EHA
Recommendation for hematologists in COVID-19 crisis
As COVID19 progresses limited information is available in hematology to manage patient care during the pandemic. The EHA Scientific Working Group Infections in Hematology has developed key questions and answers to stand by hematology professionals in the COVID19 crisis.
EHA statement on coronavirus (COVID-19)
The European Hematology Association (EHA) closely monitors the latest developments on the spreading of the Coronavirus (COVID-19).
Meet Eva Hellström-Lindberg, our Volunteer of the Month
I was nominated to be on the EHA Ballot in 2000 and to my surprise and happiness, I was elected as Councilor. I became President-elect in 2003 and was the EHA President 2005-2007.
ATMPs and CAR-T: the uptake challenge
Advanced therapy medicinal products (ATMPs) are a game changer for improving the lives of patients with severe to life-threatening diseases. Yet, despite fast-paced innovation in the field, few ATMPs have reached the EU market and benefited patients. The challenges facing their adoption by health systems are complex. A test case is the uptake of CAR T-cell therapy; what are the hurdles and what action is needed from stakeholders?
EU health policy: limited scope, high ambition
While health policy remains the primary responsibility of Member States, in many areas the added value of EU-level collaboration and harmonization has increased. EU initiatives in health have shown a mixed record in terms of impact, but hopes are high for the latest one, the ambitious Europe’s Beating Cancer Plan.
Meet Helen Papadaki, our January volunteer of the month
Can you tell us what you do for EHA and when you started? I am currently a Councilor of the EHA Board for the period 2016-2020, chair of the EHA Membership…